CDXS
CEO, Board Member
2025-01-01–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2025-01-01–present
Source not stated
Start not stated–present
Proxy statement
Start not stated–2025-04-24
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
CDXS
CEO, Board Member
2025-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Codexis, Inc. (CDXS) | President and Chief Executive Officer | $524,732 | $2,323,279 |
| 2024 | Codexis, Inc. (CDXS) | Executive Vice President and Chief Technical Officer | $115,382 | $1,102,937 |
| 2022 | Allogene Therapeutics, Inc. (ALLO) | Chief Technical Officer | $490,000 | $5,279,236 |
| 2021 | Allogene Therapeutics, Inc. (ALLO) | Chief Technical Officer | $475,000 | $3,547,012 |
| 2020 | Allogene Therapeutics, Inc. (ALLO) | Chief Technical Officer | $440,000 | $2,483,819 |
| 2019 | Allogene Therapeutics, Inc. (ALLO) | Chief Technical Officer | $425,000 | $3,127,975 |
| 2018 | Allogene Therapeutics, Inc. (ALLO) | Chief Technical Officer | $233,265 | $1,836,614 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.